Young-Joon Park

Title: Young-Joon Park: Innovator in Pharmaceutical Composition

Introduction

Young-Joon Park is a notable inventor based in Gwacheon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance drug stability and patient compliance. With a total of 2 patents, his work is recognized for its innovative approach to drug formulation.

Latest Patents

Young-Joon Park's latest patents include a pharmaceutical composition comprising dutasteride and propylene glycol monolaurate. This invention focuses on improving the stability of dutasteride, a poorly soluble drug used as a 5-alpha reductase inhibitor. The patent details a process for preparing a capsule formulation that is smaller in size than the commercial dutasteride capsule formulation (AVODART®) while maintaining an equivalent dissolution rate. This formulation aims to enhance patient compliance and improve the overall stability of the drug.

Career Highlights

Young-Joon Park is currently associated with Yuyu Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug formulations and patient outcomes.

Collaborations

He has collaborated with notable coworkers such as Seyeon Kim and Kyeongjin Ahn, contributing to the advancement of pharmaceutical technologies.

Conclusion

Young-Joon Park's contributions to pharmaceutical compositions demonstrate his dedication to innovation in drug formulation. His work not only enhances the stability of important medications but also improves patient compliance, marking him as a significant figure in the field.